IL100621A - 5-(4'-(2-alkyl-4-chloro-5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1-imidazolylmethyl)biphenyl-2-yl)-1h-tetrazol derivatives their preparation and pharmaceutical compositions containing them - Google Patents

5-(4'-(2-alkyl-4-chloro-5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1-imidazolylmethyl)biphenyl-2-yl)-1h-tetrazol derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL100621A
IL100621A IL10062192A IL10062192A IL100621A IL 100621 A IL100621 A IL 100621A IL 10062192 A IL10062192 A IL 10062192A IL 10062192 A IL10062192 A IL 10062192A IL 100621 A IL100621 A IL 100621A
Authority
IL
Israel
Prior art keywords
denotes
formula
compounds
methyl
ethyl
Prior art date
Application number
IL10062192A
Other languages
English (en)
Other versions
IL100621A0 (en
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of IL100621A0 publication Critical patent/IL100621A0/xx
Publication of IL100621A publication Critical patent/IL100621A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Reinforced Plastic Materials (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
IL10062192A 1991-01-31 1992-01-09 5-(4'-(2-alkyl-4-chloro-5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1-imidazolylmethyl)biphenyl-2-yl)-1h-tetrazol derivatives their preparation and pharmaceutical compositions containing them IL100621A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0020991A AT395853B (de) 1991-01-31 1991-01-31 Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
IL100621A0 IL100621A0 (en) 1992-09-06
IL100621A true IL100621A (en) 1996-08-04

Family

ID=3484393

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10062192A IL100621A (en) 1991-01-31 1992-01-09 5-(4'-(2-alkyl-4-chloro-5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1-imidazolylmethyl)biphenyl-2-yl)-1h-tetrazol derivatives their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (1) US5254574A (ja)
EP (1) EP0497121B1 (ja)
JP (1) JPH0641099A (ja)
KR (1) KR920014802A (ja)
CN (1) CN1034662C (ja)
AT (2) AT395853B (ja)
AU (1) AU642575B2 (ja)
CA (1) CA2060387A1 (ja)
CZ (1) CZ27592A3 (ja)
DE (1) DE59208058D1 (ja)
DK (1) DK0497121T3 (ja)
EG (1) EG19886A (ja)
ES (1) ES2100242T3 (ja)
FI (1) FI920349A7 (ja)
GR (1) GR3022686T3 (ja)
HU (1) HUT62583A (ja)
IE (1) IE914501A1 (ja)
IL (1) IL100621A (ja)
LT (1) LTIP1518A (ja)
LV (1) LV10446B (ja)
MY (1) MY106314A (ja)
NO (1) NO179837C (ja)
NZ (1) NZ241293A (ja)
RU (1) RU2078764C1 (ja)
SI (1) SI9210026A (ja)
YU (1) YU48089B (ja)
ZA (1) ZA92155B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255802B (it) * 1992-08-07 1995-11-16 Luso Farmaco Inst Derivati imidazolici ad attivita' a ii antagonista
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
HU226617B1 (en) * 1998-12-14 2009-04-28 Cytrx Corp Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
EA011507B1 (ru) * 2003-08-27 2009-04-28 Зентива А.С. Способ получения калиевой соли лосартана
US7803940B2 (en) * 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DE102012206094B4 (de) 2012-04-13 2019-12-05 Adidas Ag Sohlen für Sportschuhe, Schuhe und Verfahren zur Herstellung einer Schuhsohle
DE102013202306B4 (de) 2013-02-13 2014-12-18 Adidas Ag Sohle für einen Schuh
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
USD776410S1 (en) 2013-04-12 2017-01-17 Adidas Ag Shoe
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
USD783264S1 (en) 2015-09-15 2017-04-11 Adidas Ag Shoe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000452B1 (fr) * 1977-07-12 1981-05-06 Synthelabo Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique.
US4771051A (en) * 1985-05-17 1988-09-13 A/S Ferrosan 3-substituted-4,5-dihydro-5-oxo imidazoquinazolines, their preparation, and their use in treating benzodiazepin receptor-related ailments
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3627155A1 (de) * 1986-08-11 1988-02-18 Schering Ag Imidazol-derivate
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
HU217958B (hu) * 1989-06-30 2000-05-28 E. I. Du Pont De Nemours And Co. Helyettesített imidazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra

Also Published As

Publication number Publication date
AU642575B2 (en) 1993-10-21
MY106314A (en) 1995-04-29
EP0497121B1 (de) 1997-02-26
CN1034662C (zh) 1997-04-23
ATA20991A (de) 1992-08-15
HU9200292D0 (en) 1992-04-28
AU1063492A (en) 1992-08-06
GR3022686T3 (en) 1997-05-31
DK0497121T3 (da) 1997-05-05
NO920122L (no) 1992-08-03
LV10446A (lv) 1995-02-20
NZ241293A (en) 1993-04-28
DE59208058D1 (de) 1997-04-03
EG19886A (en) 1996-05-31
IE914501A1 (en) 1992-07-29
ES2100242T3 (es) 1997-06-16
FI920349L (fi) 1992-08-01
NO179837C (no) 1996-12-27
YU48089B (sh) 1997-01-08
LV10446B (en) 1995-10-20
SI9210026A (en) 1994-09-30
CA2060387A1 (en) 1992-08-01
CZ27592A3 (en) 1993-03-17
LTIP1518A (en) 1995-06-26
AT395853B (de) 1993-03-25
CN1063689A (zh) 1992-08-19
IL100621A0 (en) 1992-09-06
EP0497121A1 (de) 1992-08-05
ATE149164T1 (de) 1997-03-15
ZA92155B (en) 1992-10-28
KR920014802A (ko) 1992-08-25
NO179837B (no) 1996-09-16
US5254574A (en) 1993-10-19
NO920122D0 (no) 1992-01-09
YU2692A (sh) 1994-11-15
FI920349A0 (fi) 1992-01-27
RU2078764C1 (ru) 1997-05-10
HUT62583A (en) 1993-05-28
JPH0641099A (ja) 1994-02-15
FI920349A7 (fi) 1992-08-01

Similar Documents

Publication Publication Date Title
US5254574A (en) New tetrazole derivatives, process for their preparation and their use
US4632934A (en) Imidazole derivatives and pharmaceutical use thereof
SK18499A3 (en) Substituted pyrimidine derivatives and their pharmaceutical use
IE56057B1 (en) Dihydropyridine derivatives,their production and use
JP2544565B2 (ja) イミダゾ―ル−５−カルボン酸誘導体の新規なアシラ―ル、それらの製造方法及び利用方法
EP0769007A1 (en) 2-ureido-benzamide derivatives
JPH01186872A (ja) ３，６−ジヒドロ−１，５（２ｈ）−ピリミジンカルボン酸エステル類
KR0152299B1 (ko) 시클로헵트이미다졸 유도체, 그의 제조방법 및 이 화합물을 함유하는 치료제
KR19980703022A (ko) 3-(비스-치환 페닐메틸렌)옥신돌 유도체
IE920243A1 (en) Therapeutic agent
AU747067B2 (en) Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics
US3632602A (en) 2-(2-arylhydrazino)-2-imidazolines
US6004966A (en) Use of xanthine oxidase inhibitors as anti-ischaemic agents
EP0169009A2 (en) Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals
US4207317A (en) 1-Aryl-4-carbamoyl-pyrazolin-5-ones
HRP920819A2 (en) New tetrazole derivatives, process for the preparation thereof and their
US3336197A (en) Phenothiazine derivative
US3351628A (en) 1-ethyl-4, 5-di-(para-methoxyphenyl)-imidazole and a salt thereof
NO153652B (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazin-derivater.
NZ207716A (en) 3-(2-furoyl)-5-alkoxy-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine derivatives and pharmaceutical compositions
SK27592A3 (sk) Tetrazolové deriváty, spôsob výroby a farmaceutické prostriedky s ich obsahom
US3888853A (en) 1,2,5,6-tetrahydropyridines
JPWO1992011233A1 (ja) アリールシアノグアニジン誘導体、その製造法およびそれを有効成分として含有するカリウムチャンネル開口薬
IE51021B1 (en) 1-aroyl-2-phenylamino-2-imidazolines,their preparation and drugs containing these compounds
JPH0940558A (ja) トロンボキサンａ２産生阻害剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void